Trial Details
COMPLETEDBasic Information
| Clinical ID | c1214 |
|---|---|
| Identifier | NCT05394805 |
| Trial Title | A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | - |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Beijing Municipality |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-06-29 |
|---|---|
| Primary Completion Date | 2024-12-26 |
| Completion Date | 2024-12-26 |